• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

Femtech Investment Round-up: August 2022

By Femtech Insider Investment Round-ups, News September 2, 2022
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Investment, News, Partnership September 26, 2025
Temasek Foundation Partners with UNICEF to Support Southeast Asian Femtech Startups
Medical Device, News, Reproductive Health July 2, 2025
ASPIVIX Expands European Presence with Distribution Partnerships Across the UK and Benelux Regions
Recent Posts
  • Cleveland Clinic Report: 45% of Women Say Their Biggest Health Concern Is Affording Care, Not Disease
  • NeuroVision Acquires Durin Life Sciences to Advance Earlier Detection of Alzheimer’s and Parkinson’s
  • Paterna Biosciences Announces It Has Grown Functional Human Sperm in the Lab
  • Vella Bioscience Launches Ebbtide, a CBD-Powered Vaginal Insert for Menstrual Cramping
  • Willow, Ema EQ, Clue, Oura, and Thrive Global Launch Women’s Health AI Consortium

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.